We’ve seen plenty of industry disruptors with the likes of Amazon and Uber. In the case of transdermal microneedle patches, the impact extends beyond typical business metrics like price or customer convenience.

Researchers at the School of Pharmacy at Queen’s University Belfast are leading a €50 million, Europe-wide, project to develop new drug treatments that could improve the lives of patients with cystic fibrosis and bronchiectasis.

Reduced prescribing for nursing home residents